Evaluation status available after sign-in
About the journal
Journal of Hematopathology is a journal published by Springer Science+Business Media in Germany. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 3,590 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Springer Science+Business Media
- ISSN
- 1868-9256 · 1865-5785
- Country
- Germany
- Access
- Not open access / not declared
- Declared publication charge
- 3,590 EUR
- Declared peer-review model
- peer_review
- Official website
- https://link.springer.com/journal/12308
Index listings
- MEDLINE · 2023-01-01
- PUBMED · 2009-05-09
- Indexing
- MEDLINE · PUBMED
- APC
- 3,590 EUR
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 85 days received→accepted — computed from PubMed (n=100)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
708
Last recorded publication year
2026
Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
25
i10-index
83
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 96%
- ORCID iDs in current deposits
- 42%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101491976
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Viral-associated cancers and disorders
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Acute Myeloid Leukemia Research
- Viral-associated cancers and disorders
Show all subjects (75)
- Viral-associated cancers and disorders
- Hematological disorders and diagnostics
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Chronic Lymphocytic Leukemia Research
- CNS Lymphoma Diagnosis and Treatment
- Cutaneous lymphoproliferative disorders research
- Acute Lymphoblastic Leukemia research
- Retinoids in leukemia and cellular processes
- Hematological disorders and diagnostics
- Hematological disorders and diagnostics
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Myeloid Leukemia Treatments
- Chronic Myeloid Leukemia Treatments
- CNS Lymphoma Diagnosis and Treatment
- Eosinophilic Disorders and Syndromes
- Eosinophilic Disorders and Syndromes
- Acute Lymphoblastic Leukemia research
- Acute Lymphoblastic Leukemia research
- CNS Lymphoma Diagnosis and Treatment
- Cutaneous lymphoproliferative disorders research
- Multiple Myeloma Research and Treatments
- Cutaneous lymphoproliferative disorders research
- Histiocytic Disorders and Treatments
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- Lymphadenopathy Diagnosis and Analysis
- Clinical Laboratory Practices and Quality Control
- T-cell and B-cell Immunology
- Chronic Myeloid Leukemia Treatments
- Histiocytic Disorders and Treatments
- Histiocytic Disorders and Treatments
- Immunodeficiency and Autoimmune Disorders
- Immunodeficiency and Autoimmune Disorders
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Multiple Myeloma Research and Treatments
- Multiple Myeloma Research and Treatments
- Autoimmune and Inflammatory Disorders Research
- Hemoglobinopathies and Related Disorders
- CAR-T cell therapy research
- Platelet Disorders and Treatments
- Hemoglobinopathies and Related Disorders
- CAR-T cell therapy research
- Hemoglobinopathies and Related Disorders
- Retinoids in leukemia and cellular processes
- Blood groups and transfusion
- Retinoids in leukemia and cellular processes
- T-cell and Retrovirus Studies
- T-cell and Retrovirus Studies
- Immunodeficiency and Autoimmune Disorders
- Autoimmune and Inflammatory Disorders Research
- Blood groups and transfusion
- Autoimmune and Inflammatory Disorders Research
- Blood disorders and treatments
- Hematopoietic Stem Cell Transplantation
- Hematopoietic Stem Cell Transplantation
- Blood disorders and treatments
- Blood disorders and treatments
- Hematopoietic Stem Cell Transplantation
- Blood groups and transfusion
- IgG4-Related and Inflammatory Diseases
- IgG4-Related and Inflammatory Diseases
- Publishing and Scholarly Communication
- Eosinophilic Disorders and Syndromes
- Sarcoma Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ